Ubs Oconnor LLC Procept Bio Robotics Corp Transaction History

Ubs Oconnor LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$40.38 - $50.75 $262,470 - $329,875	-6,500 Reduced 32.97%	13,217 $653,000
Q4 2023 Feb 14, 2024	SELL	$24.89 - $43.41 $383,281 - $668,470	-15,399 Reduced 43.85%	19,717 $826,000
Q3 2023 Nov 14, 2023	SELL	$30.02 - $38.81 $480,320 - $620,960	-16,000 Reduced 31.3%	35,116 $1.15 Million
Q2 2023 Aug 14, 2023	BUY	$26.7 - $37.02 $1.36 Million - $1.89 Million	51,116 New	51,116 $1.81 Billion
Q1 2023 May 15, 2023	BUY	$26.64 - $39.74 $801,038 - $1.19 Million	30,069 Added 253.23%	41,943 $1.19 Million
Q4 2022 Feb 14, 2023	BUY	$38.78 - $46.78 $460,473 - $555,465	11,874 New	11,874 $0

277

39.5M

262K

257K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $3.1B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

Stay updated on Ubs Oconnor LLC with notifications on news.